Pethidine in emergency departments: promoting evidence-based prescribing

Karen I Kaye,* Susan A Welch,^† Linda V Graudins,^‡ Andis Graudins,§ Tai Rotem,¶ Sharon R Davis,** Richard O Day^†^†

1 NSW Therapeutic Advisory Group, PO Box 766, Darlinghurst, NSW 2010.
3 Clinical Pharmacology and Toxicology, St Vincent's Hospital, Sydney, NSW.
4 Sydney Children's Hospital, Sydney, NSW.
5 Clinical and Experimental Toxicology Unit, Prince of Wales Hospital, Sydney, NSW; and Senior Lecturer (Conjoint), University of New South Wales.
6 School of Public Health and Community Medicine, University of New South Wales, Sydney, NSW.

Correspondence: nswtag@stvincents.com.au

1. The National Medicines Policy Document. National Medicines Policy 2000. Canberra: Australian Government Department of Health and Ageing, 2000. Available at: http://www.health.gov.au/internet/wcms/publishing.nsf/Content/nmp-objectives-policy.htm (accessed Nov 2005).<eMJA full text>
2. Quality Use of Medicines (QUM) strategy. Canberra: Australian Government Department of Health and Ageing, 2000. Available at: http://www.health.gov.au/internet/wcms/publishing.nsf/Content/nmp-pdf-natstrateng-cnt.htm (accessed Nov 2005).

Online responses are no longer available. Please refer to our instructions for authors page for more information.